HIV Primary Care Guidelines

The Manitoba HIV Program endorses the BC Center for Excellence in HIV/AIDS Primary Care Guidelines.

Treatment As Prevention 

Undetectable = Un-transmittable (U=U)

The importance of viral load suppression (or an “undetectable” viral load) for prevention of HIV transmission is well evidenced.

The evidence is in: If you are HIV+, take treatment and maintain an undetectable viral load, you can have sex knowing that you won’t pass HIV to your sex partner.

In short, when HIV is undetectable, it’s untransmittable.

LEARN MORE 

Pre-Exposure Prophylaxis (PrEP)

Pre-Exposure Prophylaxis (PrEP) is a way for an HIV-negative person at risk of HIV infection to reduce their risk.

  • One form of PrEP involves taking the antiretroviral medication Tenofovir DF 300 mg/Emtricitabine 200 mg (brand name = Truvada) on a daily basis.
  • Tenofovir/Emtricitabine (Truvada) for PrEP has been approved by Health Canada.

LEARN MORE

Post-Exposure Prophylaxis (PEP)

Post-exposure prophylaxis, or PEP, is a way to help prevent the transmission of HIV in an HIV-negative person after a potential exposure.

  • PEP is a regimen of HIV drugs that needs to be taken every day for 4 weeks.
  • PEP should be taken as soon as possible after a suspected exposure to HIV as it is most effective within 72 hours.

LEARN MORE

Health Education Materials

CATIE Ordering Center will provide patient and client educational materials to your clinic free of charge. Please place orders directly, here:

CATIE ORDERING CENTER

Patient Handout: If You Just Found Out

DOWNLOAD PATIENT HANDOUT